Show simple item record

Authordc.contributor.authorDíaz Valdivia, Natalia 
Authordc.contributor.authorBravo, Denisse 
Authordc.contributor.authorHuerta, Hernán 
Authordc.contributor.authorHenríquez, Soledad 
Authordc.contributor.authorGabler Neale, Fernando 
Authordc.contributor.authorVega Blanco, María Margarita 
Authordc.contributor.authorRomero Osses, Carmen 
Authordc.contributor.authorCalderón, Claudia 
Authordc.contributor.authorOwen, Gareth I. 
Authordc.contributor.authorLeyton Campos, Lisette 
Authordc.contributor.authorQuest, Andrew F. G. 
Admission datedc.date.accessioned2015-09-02T02:29:18Z
Available datedc.date.available2015-09-02T02:29:18Z
Publication datedc.date.issued2015
Cita de ítemdc.identifier.citationBMC Cancer (2015) 15:463en_US
Identifierdc.identifier.otherDOI 10.1186/s12885-015-1477-5
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/133352
General notedc.descriptionArtículo de publicación ISIen_US
Abstractdc.description.abstractBackground: Caveolin-1 (CAV1) has been implicated both in tumor suppression and progression, whereby the specific role appears to be context dependent. Endometrial cancer is one of the most common malignancies of the female genital tract; however, little is known about the role of CAV1 in this disease. Methods: Here, we first determined by immunohistochemistry CAV1 protein levels in normal proliferative human endometrium and endometrial tumor samples. Then using two endometrial cancer cell lines (ECC: Ishikawa and Hec-1A) we evaluated mRNA and protein levels of CAV1 by real time qPCR and Western blot analysis, respectively. The role of CAV1 expression in ECC malignancy was further studied by either inducing its expression in endometrial cancer cells with the tumor promotor 12-O-tetradecanoyl-phorbol-13-acetate (4 beta-TPA) or decreasing expression using short-hairpin RNA constructs, and then evaluating the effects of these changes on ECC proliferation, transmigration, matrigel invasion, and colony formation in soft agar. Results: Immunohistochemical analysis of endometrial epithelia revealed that substantially higher levels of CAV1 were present in endometrial tumors than the normal proliferative epithelium. Also, in Ishikawa and Hec-1A endometrial cancer cells CAV1 expression was readily detectable. Upon treatment with 4 beta-TPA CAV1 levels increased and coincided with augmented cell transmigration, matrigel invasion, as well as colony formation in soft agar. Reduction of CAV1 expression using short-hairpin RNA constructs ablated these effects in both cell types whether treated or not with 4 beta-TPA. Alternatively, CAV1 expression appeared not to modulate significantly proliferation of these cells. Conclusion: Our study shows that elevated CAV1, observed in patients with endometrial cancer, is linked to enhanced malignancy of endometrial cancer cells, as evidenced by increased migration, invasion and anchorage-independent growth.en_US
Patrocinadordc.description.sponsorshipFONDECYT 1130250-7080152-1095127en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherBioMed Centralen_US
Type of licensedc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Keywordsdc.subjectCaveolin-1en_US
Keywordsdc.subjectEndometrial canceren_US
Keywordsdc.subjectProliferationen_US
Keywordsdc.subjectMigrationen_US
Keywordsdc.subjectInvasionen_US
Títulodc.titleEnhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cellsen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 Chile
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile